| 1. Micro-sphere culture gathers cancer stem cell and its potential clinical application |
Page:136—141 |
| 2. Clinical research progress on the efficacy and safety of bevacizumab in treating ad-vanced non-small cell lung cancer |
Page:129—135 |
| 3. Analysis of the correlation between rs8444 polymorphisms located within LASS2-3′-UTR and susceptibility of bladder cancer |
Page:107—111 |
| 4. Preclinical evaluation of recombinant herpes simplex virus oHSV2 in colorectal cancer |
Page:101—106 |
| 5. Advances in pathology of soft tissue tumors |
Page:14—18 |
| 6. Present perceptions and trends of surgical margin in soft tissue sarcoma in limbs and trunk |
Page:2—6 |
| 7. Epidemiology of stomach cancer in China |
Page:52—58 |
| 8. Advances in molecular targeted therapy for soft tissue sarcomas |
Page:7—13 |
| 9. High expression of WNT5A in small cell lung cancer and promotion of cell migration by phosphorylation of JNK |
Page:46—51 |
| 10. Factors related to contralateral central lymph node metastasis in clinically node-nega-tive papillary thyroid carcinoma |
Page:41—45 |
| 11. Clinical features and prognosis of 25 cases of soft tissue sarcoma with soft tissue me-tastasis |
Page:36—40 |
| 12. TBX2 gene mutation and the clinical significance of related proteins expression in ma-lignant peripheral nerve sheath tumor |
Page:29—35 |
| 13. Efficacy of bodyγ-knife with radiosensitizer and/or hyperthermia for recurrent soft tis-sue sarcoma |
Page:24—28 |
| 14. Radiotherapy for soft tissue sarcoma |
Page:19—23 |
| 15. Diagnosis value of ultrasound-guided core-needle biopsy in breast masses under BI-RADS categories 4A to 4C |
Page:83—86 |
| 16. Correlation between preoperative NLR, PLR, and RDW and clinical pathological param-eters in gastric cancer patients |
Page:78—82 |
| 17. Research progress on lncRNAs in haematopoietic and lymphoid tissue tumors |
Page:96—99 |
| 18. Case-control study of the risk of esophageal cancer in Xinjiang |
Page:92—95 |
| 19. Clinicopathological characteristics of axillary lymph node metastasis in lung cancer |
Page:87—91 |
| 20. MiR-200c/141 methylation inhibits the expression of miR-200c and miR-141 in gastric cancer |
Page:73—77 |
| 21. Progress on radionuclide-labeled small peptides in targeting tumor angiogenesis |
Page:68—72 |
| 22. Targeting DNA methylation in the treatment of acute myeloid leukemia |
Page:64—67 |
| 23. Application of droplet digital PCR in the precision treatment of breast cancer |
Page:146—149 |
| 24. Advances in the treatment for HER2-positive advanced gastric cancer |
Page:59—63 |
| 25. Advances in circulating tumor cells detection and the colorectal cancer recurrence or metastasis |
Page:142—145 |
| 26. Image-guided determination of actual dose for nasopharyngeal carcinoma patients treated with helical tomotherapy |
Page:123—128 |
| 27. Expression and correlation of EHD2 and E-cadherin in hepatocellular carcinoma |
Page:118—122 |
| 28. Advances in antiangiogenic drug-induced hypertension |
Page:238—245 |
| 29. Research progress on small cell lung cancer with syndrome of inappropriate secretion of antidiuretic hormone |
Page:233—237 |
| 30. Clinical observation of capecitabine and temozolomide in the treatment of advanced pancreatic neuroendocrine tumors |
Page:228—232 |
| 31. Clinical outcomes of epidermal growth factor receptor tyrosine kinase inhibitors in re-current adenosquamous carcinoma of the lung after resection |
Page:269—273 |
| 32. Relationship between the overexpression of DNA methyltransferase 3B4 and clear cell renal cell carcinoma |
Page:264—268 |
| 33. Accurate pathological diagnosis of thyroid cancer in the era of precision medicine |
Page:181—185 |
| 34. Advances in intraductal therapy for breast cancer prevention and treatment |
Page:177—180 |
| 35. 50 cases of clinical diagnosis and treatment of solid-pseudopapillary tumor of pancreas |
Page:173—176 |
| 36. Role of postoperative chemotherapy in patients with early-stage pulmonary large-cell neuroendocrine carcinoma after resection |
Page:169—172 |
| 37. Appropriate approach for laparoscopic lymph node dissection of advanced gastric cancer |
Page:151—154 |
| 38. Advances in the mechanism of action of L1CAM in pancreatic cancer invasion and me-tastasis |
Page:349—353 |
| 39. Multidisciplinary team confirmed the simultaneous diagnosis of CLL and AML-M5 |
Page:337—343 |
| 40. Prognostic factors of combined small cell lung cancer after surgical resection |
Page:331—336 |
| 41. Research progress on relationship between brain metastasis from lung cancer and ex-tracellular vesicles |
Page:404—408 |
| 42. Advancement of aptamer-based detection for circulating tumor cells |
Page:400—403 |
| 43. Clinicopathologic analysis of 3299 patients with thyroid tumors in Nanchong |
Page:395—399 |
| 44. Application of three-dimensional visualization technology in preoperative assessment of hilar cholangiocarcinoma |
Page:390—394 |
| 45. Clinical analysis of autologous peripheral blood hematopoietic stem cell mobilization regimen in 61 lymphoma patients |
Page:377—383 |
| 46. Follow-up study on biochemical and structural response in progressive radioactive io-dine-refractory differentiated thyroid cancer patients treated with apatinib |
Page:371—376 |
| 47. Genetic polymorphisms of DNA repair genes XPD, XPC, and XRCC4 in relation to colorectal cancer susceptibility |
Page:365—370 |
| 48. Expression and function of LETM2 in esophageal squamous carcinoma |
Page:355—359 |
| 49. Predictive value of preoperative and postoperative serum tumor markers CEA, CA19-9, and CA72-4 in the diagnosis of gastric cancer recurrence at different stages |
Page:324—330 |
| 50. Clinical efficacy and safety of L-asparaginase combined with GDP regimen in treat-ment of patients with extranodal NK/T-cell lymphoma |
Page:321—323 |
| 51. Effects of miR-200a on the proliferation of lung cancer cells by inhibiting YAP1 |
Page:311—315 |
| 52. Inhibitory effect of combined niclosamide and cisplatin on adrenocortical carcinoma xenografts in nude mice |
Page:306—310 |
| 53. Current status and progress of preoperative pulmonary function evaluation in patients with lung cancer |
Page:301—305 |
| 54. Detection of lymphocyte immune function in peripheral blood of patients with ad-vanced gastric cancer |
Page:224—227 |
| 55. Correlation between preoperative CRP/Alb ratio and lymph node metastasis in pa-tients with gastric cancer |
Page:210—213 |
| 56. Expression of tissue neuronal cell adhesion molecule 56, chromogranin A, and synapto-physin and its relationship with clinicopathological features and prognosis in 92 Chi-nese patients with primary esophageal small cell carcinoma |
Page:204—209 |
| 57. Establishment of human gastric cancer model in normal immune mice based on micro-carrier 6 |
Page:199—203 |
| 58. Immunotherapy of acute leukemia:clinical experience and prospect |
Page:249—252 |
| 59. Research progress on myoepithelial carcinoma |
Page:253—257 |
| 60. Research progress on the anti-tumor immunity of Th9 cells and its mechanism |
Page:294—298 |
| 61. Pre-radiation neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, prognostic nutritional index, and CA19-9 as prognostic factors in pancreatic cancer patients treat-ed with radiotherapy |
Page:289—293 |
| 62. Correlation of neutrophils to lymphocyte ratio and platelet to lymphocyte ratio with prognosis of hepatocellular carcinoma patients treated with transarterial chemoembo-lization |
Page:283—288 |
| 63. Prognostic analysis and comparison of the efficacy and complication of different radio-therapy techniques for postoperative early cervical squamous cell carcinoma |
Page:278—282 |
| 64. Comprehensive therapeutic strategies regarding immune checkpoint |
Page:782—786 |
| 65. Research progress on the role of circRNA in gastrointestinal tumor |
Page:778—781 |
| 66. Comparative analysis on survival of the patients with esophageal squamous cell carci-noma from rural and urban regions |
Page:773—777 |
| 67. Clinical efficacy of apatinib in treating refractory triple-negative advanced breast cancer |
Page:769—772 |
| 68. Clinical application of preoperative interventional embolization for benign and malig-nant retroperitoneal tumor |
Page:764—768 |
| 69. Clinicopathological features of 11 inflammatory myofibroblastic tumor cases |
Page:760—763 |
| 70. Expression and clinical significance of lymphocyte function-associated antigen 3 (LFA-3) in low-grade glioma |
Page:755—759 |
| 71. A new mitochondria-targeted platinum complex Mor-platin inhibits HepG2 cell prolif-eration and cell invasion |
Page:750—754 |
| 72. Effect of osimertinib combined bevacizumab on lung adenocarcinoma with EGFR T790M mutation and its mechanisms |
Page:744—749 |
| 73. Effect of afatinib on the proliferation and apoptosis of human breast cell lines and its mechanisms |
Page:739—743 |
| 74. Characteristics and adjuvant medical treatment for elderly women with breast cancer |
Page:733—738 |
| 75. Combining chemotherapy with immunotherapy:from bench to bedside |
Page:452—458 |
| 76. Advances in breast cancer epidemiology based on molecular subtyping |
Page:449—451 |
| 77. Research progress on expression of Epstein-Barr virus genes in EBV associated gastric carcinoma |
Page:444—448 |
| 78. Clinical analysis of single-and multiple-port thoracoscopic lobectomy for lung cancer |
Page:440—443 |
| 79. Retrospective study on chemotherapy for advanced biliary tract carcinoma |
Page:429—433 |
| 80. Chimeric antigen receptor T cell based therapeutic modality in solid tumors |
Page:415—417 |
| 81. Principles and strategies for the prevention and treatment of parathyroid and larynge-al nerve injuries during thyroid surgery |
Page:409—414 |
| 82. Clinical research of icotinib combined with subarachnoid space implantable pump for the treatment of leptomeningeal metastases from lung adenocarcinoma |
Page:437—439 |
| 83. Treatment strategy of complete response cases after neoadjuvant radiotherapy in rec-tal cancer |
Page:434—436 |
| 84. Clinicopathological studies on primary renal lymphoma |
Page:483—487 |
| 85. Effects of HDAC5 on the proliferation and apoptosis of the gastric cancer cell line SGC-7901 |
Page:469—473 |
| 86. Effects of arsenic trioxide combined with first-line chemotherapy on osteosarcoma of patients with pulmonary extremity metastasis |
Page:502—507 |
| 87. Relationship between preoperative FIB-4 and hepatocellular carcinoma prognosis after curative resection |
Page:498—501 |
| 88. Clinical significance of expression and phosphorylation of FAK in human osteosarcoma |
Page:474—482 |
| 89. Manifestation and therapies of EGFRI-induced dermatological toxicities |
Page:673—676 |
| 90. Efficacy and safety of multiple-dose 5-HT3 receptor antagonists in preventing multi-day-based and highly emetogenic chemotherapy-induced nausea and vomiting |
Page:667—672 |
| 91. PEG-rhG-CSF for peripheral blood stem cell mobilization in patients with relapsed or refractory malignant lymphoma |
Page:662—666 |
| 92. Comparison of rectal cancer tumor volume parameters measured by MRI sequences and CT with those by pathological specimen |
Page:656—661 |
| 93. Mechanisms of differentiation of omental-adipose stromal cells promoted by gastric cancer cells |
Page:651—655 |
| 94. Histone deacetylase inhibitor down-regulated the expression of HER-2 in breast cancer through the changes in miRNA |
Page:644—648 |
| 95. Progress on breast cancer research in patients aged 25 years and younger |
Page:640—643 |
| 96. Advances of target therapy in hormone-receptor-positive breast cancer |
Page:635—639 |
| 97. Clinical research progress on treatments for HER-2-positive breast cancer |
Page:630—634 |
| 98. Clinical progress and future of targeted therapy for breast cancer |
Page:625—629 |
| 99. Research progress in the mechanism of telomeric shelterin component TRF2 in tumori-genesis and tumor treatment |
Page:835—838 |
| 100. Research progress on PD-1/PD-L1 inhibitors in prostate cancer immunotherapy |
Page:831—834 |
| 101. Analysis of the curative effect of extensive pterional approach combined with cutting of the zygomatic arch for the resection of large sphenoid ridge meningioma |
Page:822—825 |
| 102. Relationship of clinicopathological characteristics with neoadjuvant chemotherapy efficacy and prognosis of inflammatory breast cancer patients |
Page:816—821 |
| 103. Analysis of clinical characteristics and prognosis of 63 cases of pancreatic neuroendo-crine tumor |
Page:810—815 |
| 104. Progress on glioblastoma multiforme treatment with chimeric antigen receptor T-cells |
Page:794—799 |
| 105. Efficacy of laparoscopy-assisted radical gastrectomy for elderly patients with gastric cancer |
Page:800—804 |
| 106. Role of insulin-like growth factor binding protein 2 in tumor malignant biological be-havior and its clinical application |
Page:826—830 |
| 107. Risk factors for high-volume lymph node metastases in cN0 papillary thyroid microcar-cinoma |
Page:805—809 |
| 108. Current status and prospect of prognostic systems for intrahepatic cholangiocarcinoma |
Page:567—570 |
| 109. Effect of kinase PLK4 on the proliferation of glioma cells in vitro |
Page:685—688 |
| 110. Research progress on PD-1/PD-L1 in the treatment of non-small cell lung cancer |
Page:726—730 |
| 111. Clinical analysis of 667 adrenal incidentalomas |
Page:722—725 |
| 112. Anorectal malignant melanoma:diagnosis, treatment, and prognostic analysis of 36 cases |
Page:717—721 |
| 113. Prognosis of 153 non-small cell lung cancer patients with pleural dissemination after surgery |
Page:712—716 |
| 114. Clinical efficacy of laparoscopic liver resection versus open liver resection for hepato-cellular carcinoma |
Page:706—711 |
| 115. Clinical research on apatinib combined with Xiaoyan decoction for the treatment of non-squamous non-small cell lung cancer |
Page:701—705 |
| 116. Expression ofβ1 integrin, Rac1, and RhoA in invasive micropapillary breast carcinoma |
Page:695—700 |
| 117. ERK5 and MMP-9 expression levels in osteosarcoma and their clinical significance |
Page:689—694 |
| 118. Multicenter postmarketing clinical study on using pegylated recombinant human gran-ulocyte-colony stimulating factor to prevent chemotherapy-induced neutropenia |
Page:679—684 |
| 119. Research progress on MCL-1 and its inhibitors in hematological malignancies |
Page:562—566 |
| 120. Pulmonary toxicity related to EGFR-TKI monotherapy or its combination with radia-tion as treatment for non-small cell lung cancer |
Page:558—561 |
| 121. Cancer mortality in Zhejiang cancer registration areas from 2010 to 2014 |
Page:552—557 |
| 122. Outcome and prognostic markers of neoadjuvant chemotherapy and cut-off value of Ki-67 in 158 breast cancer patients |
Page:547—551 |
| 123. Efficacy and safety of docetaxel plus apatinib as a second-line treatment for advanced non-squamous non-small cell lung cancer |
Page:544—546 |
| 124. Expression of microtubule-associated protein 2 correlates with better prognosis of pancreatic neuroendocrine tumors |
Page:532—538 |
| 125. Doxorubicin induces enrichment of stem-like cells in osteosarcoma by activating Notch signaling |
Page:527—531 |
| 126. Possible mechanism and significance of rare p53 mutation in Epstein-Barr virus-associated gastric cancer |
Page:522—526 |
| 127. Advances in research on mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in RAS wild-type metastatic colorectal cancer |
Page:517—521 |
| 128. Prognosis-relevant factors in primary vaginal carcinoma |
Page:612—615 |
| 129. The 18F-fluorodeoxyglucose positron emission tomograhy in predicting residual retro-peritoneal tumor after chemotherapy of testis germ cell tumors |
Page:608—611 |
| 130. Assessment of features and prognostic factors of 146 gastric cancer patients with bone metastasis |
Page:594—599 |
| 131. Relationship between expression of PD-L1 and microsatellite instability of colorectal cancer and its significance |
Page:589—593 |
| 132. Enhanced effect of immunomagnetic beads on micro-CT scan of the lung adenocarci-noma mouse model |
Page:583—588 |
| 133. Effect of TRPV5 and TRPV6 channels on the biological behaviors of SW480 colon cancer cell line |
Page:577—582 |
| 134. Advances in personalized treatment of small cell lung cancer |
Page:571—576 |
| 135. Research progress on the mechanism and clinical data of IDO inhibitor in reversing the resistance of malignancies to PD-1 antibody by regulating MDSCs |
Page:935—938 |
| 136. Clinicopathological study of 24 cases of ovarian cellular fibromas |
Page:920—922 |
| 137. Characteristic analysis of aggressive non-Hodgkin's lymphoma complicated by autoim-mune hemolytic anemia |
Page:915—919 |
| 138. Expression of Oct4 and its prognostic role in left-and right-side colon cancer |
Page:909—914 |
| 139. Progress on metronomic chemotherapy for advanced hepatocellular carcinoma |
Page:948—952 |
| 140. Evolution theory in cancer treatment |
Page:944—947 |
| 141. Metabolic reprogramming of the de novo fatty acid synthesis pathway in cancer devel-opment and progression |
Page:939—943 |
| 142. Advances in the immunotherapy of glioma |
Page:931—934 |
| 143. Cancer incidence and mortality in Henan 2013 |
Page:923—930 |
| 144. Ibrutinib inhibits diffuse large B-cell lymphoma cell survival |
Page:903—908 |
| 145. Progress on radiotherapy for cervix cancer |
Page:899—902 |
| 146. Influence of gut microbiota on the development of tumor via the gut-brain axis |
Page:886—889 |
| 147. Therapeutic effect of transarterial chemoembolization combined with apatinib on patients with advanced hepatocellular carcinoma |
Page:880—885 |
| 148. Clinical observation of caffeic acid in the treatment of thrombocytopenia (CIT) caused by cancer chemotherapy |
Page:876—879 |
| 149. Analysis of clinicopathologic characteristics, misdiagnosis and missed diagnosis of 4 malakoplakia cases |
Page:873—875 |
| 150. Treatment of hypermyoglobinemia after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy for patients with peritoneal carcinomatosis: a cohort study on 60 patients |
Page:867—872 |
| 151. MRI-guided stereotactic supratentorial lesion biopsy:a report of 103 patients |
Page:863—866 |
| 152. Prognostic value of the combined preoperative plasma levels of fibrinogen and lym-phocyte to monocyte ratio (F-LMR) in patients with non-small cell lung cancer |
Page:857—862 |
| 153. Prognostic evaluation of high sensitivity-C reactive protein in peripheral T-cell lymphoma |
Page:851—856 |
| 154. Berberine exerts pro-apoptotic effects on PC-9 cells via activation of JNK/FOXO3 signaling |
Page:846—850 |
| 155. Anticancer effects and underlying mechanisms of HJC0152, a small-molecule STAT3 in-hibitor, on tumor invasion and migration in human head and neck squamous cell carci-noma |
Page:841—845 |
| 156. Advances in the relationship between peritoneal microenvironment and peritoneal me-tastasis in colorectal cancer |
Page:894—898 |
| 157. Research progress on long noncoding RNA in urothelial bladder carcinoma |
Page:890—893 |
| 158. Research progress on TIAM1 in pediatric neuroblastoma |
Page:1160—1164 |
| 159. Progress on EGFR-TKI in treatment of non-small cell lung cancer with S768I mutation |
Page:1155—1159 |
| 160. Biological foundation and research progress on radiotherapy combined with immuno-therapy |
Page:1151—1154 |
| 161. Application value of 3D printing technology in the surgery of sphenoid ridge meningioma |
Page:1146—1150 |
| 162. Predictive factors of skip metastasis to lateral with leaping central lymph node in papil-lary thyroid carcinoma |
Page:1141—1145 |
| 163. Profiling the dynamic changes of PBMC immune-related indicators in patients with lung cancer after chemotherapy cycles |
Page:1135—1140 |
| 164. Effect of Fructus Corni extract on B7-H6 expression in primary liver cancer of rats |
Page:1125—1129 |
| 165. Isoliquiritigenin promotes the radiosensitivity of human glioma stem cells |
Page:1120—1124 |
| 166. Research progress on chemotherapy-induced tumor microenvironment changes and tumor metastasis |
Page:1049—1054 |
| 167. Advances in antitumor functions and mechanisms of apolipoprotein A-Ⅰ |
Page:1045—1048 |
| 168. Clinical standardized evaluation of lymph node metastasis in gastric cancer |
Page:1040—1044 |
| 169. Retrospective analysis of surgical treatment and postoperative follow-up study of adult primary intraspinal tumors |
Page:1029—1033 |
| 170. Second generation sequencing detection breast cancer susceptibility gene variants for risk prediction and clinical treatment |
Page:1024—1028 |
| 171. Prognosis of cervical and posterior to level V lymph node metastasis in 406 cases of na-sopharyngeal carcinoma |
Page:1019—1023 |
| 172. Research progress on the therapy of T-cell prolymphocytic leukemia |
Page:1108—1111 |
| 173. Advances in diagnosis and treatment of internal mammary lymph node of breast cancer |
Page:1104—1107 |
| 174. Research progress on the mechanisms of chemotherapy resistance to glioblastoma in-duced by hypoxia microenvironment |
Page:1100—1103 |
| 175. Effect of BIM on advanced non-small cell lung cancer |
Page:1095—1099 |
| 176. Detection rate of colorectal adenoma and its risk factors in different areas |
Page:1090—1094 |
| 177. Integration of multiple disciplines on primary breast bidirectional synovial sarcoma |
Page:1086—1089 |
| 178. Progress on surgical resection of the primary diagnostic stageⅣbreast cancer |
Page:1055—1058 |
| 179. Low-dose computed tomography screening for lung cancer in Tianjin: a preliminary clinical analysis of baseline screening and follow-up results |
Page:1034—1039 |
| 180. Application value of superb microvascular imaging for diagnosis of renal solid masses |
Page:1082—1085 |
| 181. Clinicopathologic characteristics of non-small cell lung cancer patients with seldom mutation types of epidermal growth factor receptor and treatment analysis |
Page:1076—1081 |
| 182. Value of tumor-associated CD66b-positive neutrophils for the prediction of the recur-rence of stage Ib and IIa cervical cancer |
Page:1071—1075 |
| 183. Clinical characteristics and treatment of unicentric retroperitoneal Castleman's disease |
Page:1067—1070 |
| 184. Association of the polymorphisms in TP63 rs6790167 with risk for lung cancer in Hain-an Han population |
Page:1061—1066 |
| 185. Expression and potential role of miRNA-20a in bladder cancer |
Page:1014—1018 |
| 186. MiR-375 suppresses angiogenesis of hepatocellular carcinoma by targeting platelet-de-rived growth factor-C |
Page:1007—1013 |
| 187. Predictors for the mortality of malignant tumor patients with invasive candidiasis |
Page:1130—1134 |
| 188. The role of PD0332991 in clonogenicity of mantle cell lymphoma cells |
Page:1115—1119 |
| 189. The efficacy of thalidomide on preventing and treating radiation-induced oral mucosi-tis in nasopharyngeal carcinoma |
Page:1189—1193 |
| 190. Dexamethasone in the prophylaxis of radiation-induced pain deterioration after pallia-tive radiotherapy for bone metastases from lung cancer |
Page:1194—1198 |
| 191. Analysis of parenchymal-sparing hepatectomy in surgical treatment of colorectal liver metastases |
Page:1179—1183 |
| 192. Expression of STEAP1 in human breast cancer and its clinical significance |
Page:1175—1178 |
| 193. Research advances on EGFR-targeted therapy and acquired resistance in nonsmall cell lung cancer |
Page:1212—1216 |
| 194. Introduction and analysis of the latest changes in head and neck cancer staging |
Page:1208—1211 |
| 195. Research progress on the role of non-coding RNAs in laryngeal squamous cell carcinoma |
Page:1204—1207 |
| 196. The predictive value of tumor-infiltrating lymphocytes in patients with breast cancer treated with neoadjuvant chemotherapy |
Page:1184—1188 |
| 197. Effect of bone marrow mesenchymal stem cells on low metastatic hepatocellular carci-noma cells |
Page:1169—1174 |
| 198. Risk factors of lower limb DVT and thrombosis risk assessment after breast cancer surgery |
Page:1199—1203 |
| 199. Advances in the research on application and antitumor mechanism of snake venom |
Page:988—992 |
| 200. Research progress on spliceosome mutations in myelodysplastic syndromes |
Page:1000—1004 |
| 201. Characteristics and surgical treatment of esophageal stromal tumors |
Page:993—999 |
| 202. A comparative analysis of the incidence rates of esophageal cancer and upper diges-tive tract cancer in Cixian County, Hebei Province, China |
Page:979—987 |
| 203. Multidisciplinary decision on a rectal cancer patient with multiple synchronous pulmo-nary metastasis |
Page:973—978 |
| 204. Comparison of mammography with automated breast ultrasound system for detecting breast lesions |
Page:969—972 |
| 205. BTK expression and its clinical significance in 32 cases of mantle cell lymphoma |
Page:963—968 |
| 206. ASCL-1 protein expression in lung adenocarcinoma and its correlation with prognosis |
Page:958—962 |
| 207. Clinicopathological features of gastric mixed adenoneuroendocrine carcinoma |
Page:953—957 |
| 208. Current status of targeted treatment for advanced renal carcinoma in China |
Page:1223—1225 |
| 209. Expression and significance of LAPTM4B-35 and MMP-9 in patients with gastric cancer |
Page:1226—1231 |
| 210. Expression of Gli-1 and EMT-related proteins and its clinical significance in non-small cell lung cancer |
Page:1232—1237 |
| 211. Expression of CD26 in the cancerous tissue and serum of patients with endometrial car-cinoma and its diagnostic value |
Page:1238—1241 |
| 212. Expression and diagnostic value of serum miR-26a/b in patients with gastric cancer |
Page:1242—1247 |
| 213. Correlation of TUBB3 expression with chemotherapy sensitivity and clinical outcome of advanced gastric cancer treated with paclitaxel-based chemotherapy |
Page:1248—1252 |
| 214. A preliminary study of amino acid metabolomics using LC-MS/MS to predict the che-motherapeutic response of patients with advanced breast cancer |
Page:1253—1257 |
| 215. Clinical analysis of clear cell sarcoma of the kidney in children |
Page:1258—1261 |
| 216. Incidence and mortality analysis of lung cancer among residents in Qidong City of Jiangsu Province from 1993 to 2012 |
Page:1262—1267 |
| 217. Finite element analysis of the effects of individual extralevator abdominoperineal exci-sion of rectal neoplasms in the low posterior wall on the pelvic floor |
Page:1268—1271 |
| 218. Research progress on mechanism of long non-coding HOTTIP RNA in regulating diges-tive system carcinomas |
Page:1272—1276 |
